Study identifies new approach to overcome docetaxel resistance in patients with advanced prostate cancer

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other targets to treat prostate cancer are still necessary to prolong life and slow the progression of this potentially lethal disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup